MELAS syndrome

3 total trials MedDRA PT

Filter these 3 trials by phase, country, sponsor and more.

Open in Search →

An open-label extension study evaluating the safety of zagociguat in participants with MELAS who completed TIS6463-203 Pending

2024-517514-15-00 4 "Mitochondrial encephalomyopathy, lactic acidosis, and stroke"
A trial to evaluate the safety and effectiveness of the investigational drug zagociguat for the treatment of MELAS Recruitment ended

2024-515389-15-00 4 2024-12-13 "Mitochondrial encephalomyopathy, lactic acidosis, and stroke"
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharma … Ended

2023-506723-28-00 4 2025-03-20 "Mitochondrial encephalomyopathy, lactic acidosis and stroke-"

Showing 1–3 of 3 trials